DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME903F5

Real-time Bid/Ask 06:13:37 2024-06-13 EDT
0.096 EUR / 0.106 EUR 0.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-55.70%
1 month-62.59%
Date Price Change
24-06-12 0.101 -13.68%
24-06-11 0.117 -15.22%
24-06-10 0.138 -20.23%
24-06-07 0.173 -4.95%
24-06-06 0.182 -4.21%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 02:43 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME903F
ISINDE000ME903F5
Date issued 2024-02-20
Strike 80 $
Maturity 2024-09-20 (100 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.101
Spread 0.01
Spread %9.43%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
61.69 USD
Average target price
88.55 USD
Spread / Average Target
+43.55%
Consensus